OBICETRAPIB SODIUM
UNII 0X8JBE081M

Substance Identification & Data

This profile provides standardized clinical and technical data for Obicetrapib Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0X8JBE081M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 866399-88-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0X8JBE081M
CAS Registry Number
866399-88-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OBICETRAPIB SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C32H30F9N4O5.Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
WXEDTKUVWZVNTI-IINJVQNMSA-M
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
C224472
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
121596687
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1(OCCCC(=O)[O-])cnc(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]3c4cc(C(F)(F)F)ccc4N(C(=O)OCC)[C@H](CC)C3)nc1.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Obicetrapib Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

OBICETRAPIB SODIUM

Systematic Nomenclature

(2R,4S)-4-((3,5-BIS(TRIFLUOROMETHYL)BENZYL)(5-(3-CARBOXYPROPOXY)PYRIMIDIN-2-YL)AMINO)-2-ETHYL-6-TRIFLUOROMETHYL-3,4-DIHYDRO-2H-QUINOLINE-1-CARBOXYLIC ACID ETHYL ESTER SODIUM SALT
1(2H)-QUINOLINECARBOXYLIC ACID, 4-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL)(5-(3-CARBOXYPROPOXY)-2-PYRIMIDINYL)AMINO)-2-ETHYL-3,4-DIHYDRO-6-(TRIFLUOROMETHYL)-, 1-ETHYL ESTER, SODIUM SALT (1:1), (2R,4S)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus
NLM
PubChem Compound